152 related articles for article (PubMed ID: 19220164)
1. Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis.
Berger WE
Expert Opin Drug Metab Toxicol; 2009 Jan; 5(1):91-102. PubMed ID: 19220164
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
Bernstein JA; Prenner B; Ferguson BJ; Portnoy J; Wheeler WJ; Sacks HJ
Am J Rhinol Allergy; 2009; 23(5):512-7. PubMed ID: 19807985
[TBL] [Abstract][Full Text] [Related]
3. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
Berger WE; Fineman SM; Lieberman P; Miles RM
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
Banov CH; Lieberman P;
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
[TBL] [Abstract][Full Text] [Related]
5. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA
Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
[TBL] [Abstract][Full Text] [Related]
6. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
7. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
Derendorf H; Munzel U; Petzold U; Maus J; Mascher H; Hermann R; Bousquet J
Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
[TBL] [Abstract][Full Text] [Related]
10. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo.
Gehanno P; Deschamps E; Garay E; Baehre M; Garay RP
ORL J Otorhinolaryngol Relat Spec; 2001; 63(2):76-81. PubMed ID: 11244365
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
Lumry W; Prenner B; Corren J; Wheeler W
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
[TBL] [Abstract][Full Text] [Related]
12. A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.
Ridolo E; Montagni M; Melli V; Bonzano L; Incorvaia C; Canonica GW
Ther Deliv; 2015; 6(6):653-9. PubMed ID: 25913181
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
Dorow P; Aurich R; Petzold U
Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
16. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis.
Kalpaklioglu AF; Kavut AB
Am J Rhinol Allergy; 2010; 24(1):29-33. PubMed ID: 20109317
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
Wober W; Diez Crespo CD; Bähre M
Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
Falser N; Wober W; Rahlfs VW; Baehre M
Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial.
LaForce C; Dockhorn RJ; Prenner BM; Chu TJ; Kraemer MJ; Widlitz MD; D'Eletto TA; Freitag JJ
Ann Allergy Asthma Immunol; 1996 Feb; 76(2):181-8. PubMed ID: 8595539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
